<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="152888">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01715090</url>
  </required_header>
  <id_info>
    <org_study_id>NL 40248.018.12</org_study_id>
    <nct_id>NCT01715090</nct_id>
  </id_info>
  <brief_title>Web-based Insulin Titration - An Efficacy Study</brief_title>
  <official_title>Web-based Insulin Titration: Improving Diabetes Care in the Netherlands. An Efficacy Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to determine whether an intensive web-based titration
      system, called PANDIT (Patient Assisting Net-based Diabetes Insulin Titration), is effective
      in improving glycaemic control in patients with diabetes mellitus type 2 using a basal
      insulin, compared to standard care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Mean change in HbA1c</measure>
    <time_frame>Change from baseline after 13 weeks and after 26 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life and treatment satisfaction</measure>
    <time_frame>Change from baseline after 13 weeks and after 26 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total contact time with study staff (and the PANDIT system, if applicable)</measure>
    <time_frame>After 26 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects who reach the target of HbA1c &lt; 7.0%</measure>
    <time_frame>After 26 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in fasting plasma glucose</measure>
    <time_frame>Change from baseline after 13 weeks and after 26 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall incidence and rate of hypoglycaemia (mild hypoglycaemia, probable hypoglycaemia, severe hypoglycaemia and relative hypoglycaemia)</measure>
    <time_frame>After 26 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of the usage of PANDIT among patients</measure>
    <time_frame>After 26 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of important factors for patient compliance to internet-based self-care interventions</measure>
    <time_frame>After 26 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Web-based insulin titration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An online web-based insulin titration algorithm to guide patients in self-titration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Web-based insulin titration</intervention_name>
    <arm_group_label>Web-based insulin titration</arm_group_label>
    <other_name>PANDIT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female between 18 and 80 years

          -  Type 2 diabetes mellitus (diagnosed clinically) for â‰¥ 6 months

          -  Once daily basal insulin therapy usage

          -  No restriction on HbA1c or FPG

          -  BMI &lt; 40 kg/m2

          -  Ability to read and understand the Dutch language

          -  Familiarity with the Internet and use of a mobile phone

          -  Ability and willingness to adhere to the protocol

          -  Ability and willingness to use a web-based insulin self-titration system

          -  Confirmed written consent

        Exclusion Criteria:

          -  Type 1 diabetes

          -  Use of systemic corticosteroid in the last three months

          -  Recurrent severe hypoglycaemia or hypoglycaemic unawareness

          -  Active proliferative diabetic retinopathy

          -  Any clinically significant disease or disorder

          -  Mental condition rendering the patient unable to understand the nature, scope and
             possible consequences of the study

          -  Working in night shifts
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frits Holleman, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frits Holleman, MD PhD</last_name>
    <phone>00312065954</phone>
    <email>f.holleman@amc.uva.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Frits Holleman, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <results_reference>
    <citation>Simon AC, Holleman F, Hoekstra JB, De Clercq PA, Lemkes BA, Hermanides J, Peek N. Development of a web-based decision support system for insulin self-titration. Stud Health Technol Inform. 2011;169:103-7.</citation>
    <PMID>21893723</PMID>
  </results_reference>
  <results_reference>
    <citation>Simon AC, Holleman F, Gude WT, Hoekstra JB, Peek N. Safety of a web-based insulin titration system for patients with type 2 diabetes mellitus - pilot study. Stud Health Technol Inform. 2012;180:731-5.</citation>
    <PMID>22874288</PMID>
  </results_reference>
  <results_reference>
    <citation>Gude WT, Simon AC, Peute LW, Holleman F, Hoekstra JB, Peek N, Jaspers MW. Formative usability evaluation of a web-based insulin self-titration system: preliminary results. Stud Health Technol Inform. 2012;180:1209-11.</citation>
    <PMID>22874403</PMID>
  </results_reference>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 13, 2014</lastchanged_date>
  <firstreceived_date>October 22, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>F Holleman</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
